NASDAQ$NOVT

Novanta Inc · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Novanta's first quarter results for 2022 were announced, featuring revenue growth and strong customer demand.

Novanta reported strong first quarter results with a 26% increase in GAAP revenue to $204 million and a 33% increase in Adjusted EBITDA to $43.6 million. Customer demand remains robust across advanced industrial and medical application areas, with customer orders up 11% year over year, resulting in a record backlog of $586 million.

  • GAAP Revenue increased 26% to $204 million.
  • Consolidated Net Income was $18.8 million.
  • Adjusted Earnings Per Share increased 26% to $0.73.
  • Adjusted EBITDA increased 33% to $43.6 million.

Headline financials

Total Revenue

$204M

Previous: $163M+25.6%
EPS (adj)

$0.73

Previous: $0.58+25.9%
Adjusted EBITDA

$43.6M

Previous: $32.7M+33.3%
Capital Expenditures

-$6.31M

Previous: -$3.27M-93.0%
Free Cash Flow

$12.5M

Previous: $8.04M+55.6%
Net Income

$18.8M

Previous: $11.3M+66.4%
Operating Income

$24.3M

Previous: $11.1M+118.8%
Gross Profit

$90.3M

Previous: $68.7M+31.3%
Cash & Equivalents

$98.8M

Previous: $114M-13.0%
Total Assets

$1.21B

Previous: $852M+41.5%
Stock-Based Comp

$6.77M

Previous: $6.64M+2.0%

Revenue & EPS history

Novanta · Revenue · Quarterly

$204M

Q1 2022+25.6%vs Q1 2021
Beat estimate in 16 of 16 quarters(100%)
ActualEstimate

Revenue by segment

Novanta · $83.4M total across 1 segment · Q3 2023

  • Medical Solutions
    $83.4M

Forward guidance

The Company expects GAAP revenue of approximately $205 million to $213 million, demonstrating reported growth of 22% to 27%. The Company expects Adjusted Gross Profit Margin to be in the range of 45.0% to 46.0%. The Company expects Adjusted EBITDA to be in the range of $42 million to $44 million and Adjusted Diluted EPS to be in the range of $0.69 to $0.73.

Tailwinds

  • Expects strong double-digit growth in the second quarter.
  • Customer demand remains exceptionally strong across both medical and advanced industrial end markets.
  • Confident in strategic positioning.
  • Confident in the capabilities and commitment of teams.
  • Confident in product innovation.

Headwinds

  • Global backdrop of supply chain challenges.
  • Inflationary pressures.
  • Continued COVID disruptions in China.
  • War in the Ukraine.
  • Assumes no significant changes in foreign exchange rates.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+2.3%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+2.7%

Avg return

30 days after

64%

41 / 64 earnings

Positive

+22.9%

Q3 2018

Best reaction

-11.3%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.2%+10.5%+11.6%
Q4 2025-2.2%-7.9%-19.4%
Q3 2025+8.4%-17.0%-10.0%
Q1 2025-1.7%+2.4%+5.3%
Q4 2024+7.2%+4.6%-4.2%
Q3 2024+4.5%+4.9%-4.5%
Q2 2024+7.6%+9.4%+10.3%
Q1 2024-1.6%+0.1%+0.8%
Q4 2023+9.9%+12.1%+11.1%
Q3 2023-11.0%-11.0%+9.4%
Q2 2023-11.3%-11.2%-6.9%
Q1 2023+2.2%+0.5%+4.8%
Q4 2022-6.1%-3.7%+1.4%
Q3 2022-3.5%+10.5%+7.2%
Q2 2022-0.4%-0.5%-13.6%
Q1 2022+3.1%+9.5%+3.9%
Q4 2021-1.0%-2.0%+4.1%
Q3 2021-7.4%-8.2%-5.7%
Q2 2021+5.1%+3.8%+8.9%
Q1 2021+2.5%+7.0%+8.1%
Q4 2020-1.3%-4.1%-0.3%
Q3 2020-2.3%-7.5%-2.3%
Q2 2020+4.8%+3.4%-6.1%
Q1 2020+6.6%+3.8%+14.2%
Q4 2019+5.6%+8.4%-10.0%
Q3 2019-5.9%-8.3%-0.1%
Q2 2019-5.3%-8.4%+2.0%
Q1 2019-5.8%-5.3%-6.9%
Q4 2018+4.7%+4.6%+8.6%
Q3 2018+22.9%+21.7%-1.9%
Q2 2018-0.6%+1.9%+13.2%
Q1 2018+2.8%+3.9%+8.1%
Q4 2017+2.8%+0.9%-4.1%
Q3 2017+10.1%+10.1%-1.5%
Q2 2017-0.8%+1.9%+4.0%
Q1 2017+8.6%+12.0%+34.0%
Q4 2016+0.2%+3.9%+5.5%
Q3 2016-1.2%+1.5%+16.9%
Q2 2016+1.7%+2.9%+7.9%
Q1 2016-0.6%
Q4 2015+2.1%
Q3 2015+2.7%
Q2 2015+1.1%
Q1 2015+0.2%
Q4 2014+1.1%
Q3 2014+0.7%
Q2 2014+4.1%
Q1 2014+1.3%
Q4 2013+2.3%
Q3 2013+9.9%
Q2 2013-4.1%
Q1 2013+0.2%
Q4 2009-1.5%
Q4 2012-1.5%
Q3 2012+0.4%
Q2 2012-8.6%
Q1 2011+10.8%
Q1 2012+2.6%
Q4 2011+0.3%
Q3 2010+6.0%
Q3 2011+6.0%
Q4 2010+18.8%
Q2 2010+18.8%
Q2 2011+18.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro